Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VOGXVogenx, Inc.

Nasdaq · CIK 0001903784
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts91

Identity from submissions API

NameVogenx, Inc.
CIK0001903784
TickersVOGX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN863697324
LEI5299004KM33YCDWS6I69
Fiscal year end1231
State of incorporationDE DE
Phone9196595677
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3901 BARRETT DRIVE, SUITE 300
RALEIGH
NC
27609
NC
Mailing address
PO BOX 19469
RALEIGH
NC
27619
NC

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

45 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 xslF345X06/ownership.xml 0001185185-26-005572 7785
2026-11-20 4 xslF345X06/ownership.xml 0001185185-26-005570 7857
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000947871-26-001036 005-95922 261563360 34 14871
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001185185-26-005464 005-95922 261560377 34 10976
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001185185-26-005463 005-95922 261560345 34 12847
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001185185-26-005461 005-95922 261560260 34 6484
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001185185-26-005459 005-95922 261560232 34 6763
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000688 005-95922 261552291 34 17128
2026-11-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-007549 005-95922 261543868 34 15519
2026-11-06 10-Q FORM 10-Q 0001185185-26-005245 001-43441 261533064 34 4339602 1 1
2026-11-06 8-K FORM 8-K 2.02,9.01 0001185185-26-005214 001-43441 261529260 34 251047 1 1
2026-10-09 8-K FORM 8-K 5.02,7.01,9.01 0001185185-26-004679 001-43441 261452141 34 215993 1 1
2026-10-06 4 xslF345X06/ownership.xml 0001185185-26-004624 5643
2026-10-06 4 xslF345X06/ownership.xml 0001185185-26-004623 5648
2026-10-06 4 xslF345X06/ownership.xml 0001185185-26-004622 5644
2026-10-06 4 xslF345X06/ownership.xml 0001185185-26-004621 5627
2026-10-06 4 xslF345X06/ownership.xml 0001185185-26-004620 5599
2026-10-06 4 xslF345X06/ownership.xml 0001185185-26-004619 5606
2026-09-28 3 xslF345X06/ownership.xml 0001185185-26-004373 15652
2026-09-22 8-K FORM 8-K 5.02,7.01,9.01 0001185185-26-004202 001-43441 261396843 34 220920 1 1
2026-09-17 10-Q FORM 10-Q 0001185185-26-004101 001-43441 261387130 34 3645671 1 1
2026-09-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000221 005-95922 261364129 34 13138
2026-08-19 8-K FORM 8-K 8.01 0001185185-26-003628 001-43441 261295210 34 196301 1 1
2026-08-13 4 xslF345X06/ownership.xml 0001185185-26-003507 7704
2026-08-13 4 xslF345X06/ownership.xml 0001185185-26-003506 7198
2026-08-13 8-K FORM 8-K 5.03,9.01 0001185185-26-003505 001-43441 261274378 34 479990 1 1
2026-08-13 S-8 FORM S-8 0001185185-26-003503 333-298311 261274164 33 225908 1 1
2026-08-12 424B4 FORM 424B4 0001185185-26-003448 333-297487 261267870 33 4454110
2026-08-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002615 333-297487 261265151 33 1737
2026-08-11 3 xslF345X06/ownership.xml 0001185185-26-003414 47432
2026-08-11 3 xslF345X06/ownership.xml 0001185185-26-003413 28424
2026-08-11 3 xslF345X06/ownership.xml 0001185185-26-003412 7963
2026-08-11 3 xslF345X06/ownership.xml 0001185185-26-003411 29395
2026-08-11 3 xslF345X06/ownership.xml 0001185185-26-003410 47256
2026-08-11 3 xslF345X06/ownership.xml 0001185185-26-003409 23781
2026-08-11 3 xslF345X06/ownership.xml 0001185185-26-003408 47433
2026-08-11 CERT VOGX_8A_Cert_1903784.pdf 0001354457-26-000775 001-43441 261262520 34 654315
2026-08-10 8-A12B FORM 8-A12B 0001185185-26-003355 001-43441 261257482 34 27194
2026-08-10 S-1/A FORM S-1/A2 0001185185-26-003353 333-297487 261257464 33 4553910
2026-07-29 S-1/A FORM S-1/A 0001185185-26-003162 333-297487 261218875 33 7442656 1 1
2026-07-15 S-1 FORM S-1 0001185185-26-002985 333-297487 261178161 33 5451124 1 1
2026-06-30 DRS/A filename1.htm 0001185185-26-002747 377-09094 261141526 33 4296400
2026-04-02 DRS/A filename1.htm 0001185185-26-001233 377-09094 26832914 33 3499241
2026-02-20 DRS filename1.htm 0001185185-26-000633 377-09094 26658007 33 4286424
2026-01-07 D xslFormDX01/primary_doc.xml 06b 0001903784-26-000002 021-569148 26513460 33 10216

Latest XBRL company facts

One latest value per concept from companyfacts (91 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 14.86M 2026-11-05 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
ffd NetFeeAmt NetFeeAmt USD 3,222.45 2026-08-11 S-8 2026-08-13 0001185185-26-003503
ffd TtlFeeAmt TtlFeeAmt USD 3,222.45 2026-08-11 S-8 2026-08-13 0001185185-26-003503
ffd TtlOfferingAmt TtlOfferingAmt USD 23.33M 2026-08-11 S-8 2026-08-13 0001185185-26-003503
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-11 S-8 2026-08-13 0001185185-26-003503
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 10,357.5 2026-07-28 S-1/A 2026-07-29 0001185185-26-003162
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 523,570 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 1.06M 2026-06-30 2026 Q2 10-Q 2026-09-17 0001185185-26-004101
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 286,500 2026-06-30 2026 Q2 10-Q 2026-09-17 0001185185-26-004101
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 318,900 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 98.61M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4,708 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 2.49M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 561,657 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap Assets Assets USD 82.84M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AssetsCurrent Assets, Current USD 82.84M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 177,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 76.99M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 76.81M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 5.13M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 82.10M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.13M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 4.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 14.86M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 14.86M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,485 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 894,477 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap ConvertiblePreferredStockSharesReservedForFutureIssuance Convertible Preferred Stock, Shares Reserved for Future Issuance shares 0 2026-08-31 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 833,326 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.9 2025-12-08 2026 Q2 10-Q 2026-09-17 0001185185-26-004101
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 750,000 2025-12-08 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap DebtInstrumentInterestRateIncreaseDecrease Debt Instrument, Interest Rate, Increase (Decrease) pure 0.18 2025-12-08 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.12 2025-12-08 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount USD 719,043 2026-06-30 2026 Q2 10-Q 2026-09-17 0001185185-26-004101
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 3.40M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.82 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.82 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 3.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 27,000 2026-07-01 2026-08-31 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 505,842 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -390,918 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 482,717 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 61,151 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 61,151 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap InterestReceivable Interest Receivable USD 270,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 338,726 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap Liabilities Liabilities USD 842,470 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 82.84M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap LiabilitiesCurrent Liabilities, Current USD 842,470 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 76.99M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 84.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -76.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -2.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -5.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap NoninterestExpenseDirectorsFees Noninterest Expense Directors Fees USD 90,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-17 0001185185-26-004101
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -3.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap OperatingExpenses Operating Expenses USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -3.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 21,945 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 2.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 84,874 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-17 0001185185-26-004101
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 76.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 725,193 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap PrepaidInsurance Prepaid Insurance USD 523,000 2026-08-31 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 86.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -16.61M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4,524 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap SharePrice Share Price USD/shares 13 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 82.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 7.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 86.90M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 833,326 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 7.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 7.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001185185-26-005245

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →